Dr. Millard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4262 Old William Penn Highway
Suite 208
Murrysville, PA 15668Phone+1 724-325-2133- Is this information wrong?
Summary
- Dr. Nathan Millard is a pediatric hematologist/oncologist in Seattle, WA. He received his medical degree from George Washington University School of Medicine and has been in practice 13 years. He specializes in pediatric neuro-oncology.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Pediatric Neuro-Oncology, 2014 - 2015
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2004 - 2007
- George Washington University School of Medicine and Health SciencesClass of 2004
Certifications & Licensure
- PA State Medical License 2016 - 2024
- WA State Medical License 2018 - 2022
- NY State Medical License 2011 - 2018
- MD State Medical License 2007 - 2011
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma Start of enrollment: 2018 Aug 01
Publications & Presentations
PubMed
- Extramedullary Hematopoiesis in the Dura Mater During Treatment of a CNS Embryonal Tumor.Shireen S Ganapathi, Molly E Havard, Mark R. Ferguson, Bonnie Cole, Nathan Millard, Nicholas A Vitanza> ;Journal of Pediatric Hematology/oncology. 2021 Nov 1
- 21 citationsChildren with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.Erin E. Crotty, Sarah Leary, J. Russell Geyer, James M. Olson, Nathan Millard, Aimee A Sato, Ralph P. Ermoian, Bonnie Cole, Christina M. Lockwood, Vera A. Paulson, Sam...> ;Journal of Neuro-Oncology. 2020 Jun 16
- 35 citationsA phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.Oren J. Becher, Nathan E. Millard, Shakeel Modak, Brian H. Kushner, Sofia Haque, Ivan Spasojevic, Tanya M. Trippett, Stephen Gilheeney, Yasmin Khakoo, David Lyden, Kev...> ;Plos One. 2017 Jun 5
- Join now to see all
Professional Memberships
- Member
- Member
- Society for Neuro-Oncology - SNOMember
- Children's Oncology Group - COGMember
- American Society of Pediatric Hematology/Oncology - ASPHOMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: